SARS: systematic review of treatment effects.

Abstract:

BACKGROUND:The SARS outbreak of 2002-2003 presented clinicians with a new, life-threatening disease for which they had no experience in treating and no research on the effectiveness of treatment options. The World Health Organization (WHO) expert panel on SARS treatment requested a systematic review and comprehensive summary of treatments used for SARS-infected patients in order to guide future treatment and identify priorities for research. METHODS AND FINDINGS:In response to the WHO request we conducted a systematic review of the published literature on ribavirin, corticosteroids, lopinavir and ritonavir (LPV/r), type I interferon (IFN), intravenous immunoglobulin (IVIG), and SARS convalescent plasma from both in vitro studies and in SARS patients. We also searched for clinical trial evidence of treatment for acute respiratory distress syndrome. Sources of data were the literature databases MEDLINE, EMBASE, BIOSIS, and the Cochrane Central Register of Controlled Trials (CENTRAL) up to February 2005. Data from publications were extracted and evidence within studies was classified using predefined criteria. In total, 54 SARS treatment studies, 15 in vitro studies, and three acute respiratory distress syndrome studies met our inclusion criteria. Within in vitro studies, ribavirin, lopinavir, and type I IFN showed inhibition of SARS-CoV in tissue culture. In SARS-infected patient reports on ribavirin, 26 studies were classified as inconclusive, and four showed possible harm. Seven studies of convalescent plasma or IVIG, three of IFN type I, and two of LPV/r were inconclusive. In 29 studies of steroid use, 25 were inconclusive and four were classified as causing possible harm. CONCLUSIONS:Despite an extensive literature reporting on SARS treatments, it was not possible to determine whether treatments benefited patients during the SARS outbreak. Some may have been harmful. Clinical trials should be designed to validate a standard protocol for dosage and timing, and to accrue data in real time during future outbreaks to monitor specific adverse effects and help inform treatment.

journal_name

PLoS Med

journal_title

PLoS medicine

authors

Stockman LJ,Bellamy R,Garner P

doi

10.1371/journal.pmed.0030343

subject

Has Abstract

pub_date

2006-09-01 00:00:00

pages

e343

issue

9

eissn

1549-1277

issn

1549-1676

pii

06-PLME-RA-0015R2

journal_volume

3

pub_type

杂志文章,评审
  • Scaling up global health interventions: a proposed framework for success.

    abstract::Drawing upon interviews with experts and a review of the literature, Gavin Yamey proposes a new framework for scaling up global health interventions. ...

    journal_title:PLoS medicine

    pub_type: 杂志文章

    doi:10.1371/journal.pmed.1001049

    authors: Yamey G

    更新日期:2011-06-01 00:00:00

  • Integration of postpartum healthcare services for HIV-infected women and their infants in South Africa: A randomised controlled trial.

    abstract:BACKGROUND:As the number of HIV-infected women initiating lifelong antiretroviral therapy (ART) during pregnancy increases globally, concerns have emerged regarding low levels of retention in HIV services and suboptimal adherence to ART during the postpartum period. We examined the impact of integrating postpartum ART ...

    journal_title:PLoS medicine

    pub_type: 杂志文章,随机对照试验

    doi:10.1371/journal.pmed.1002547

    authors: Myer L,Phillips TK,Zerbe A,Brittain K,Lesosky M,Hsiao NY,Remien RH,Mellins CA,McIntyre JA,Abrams EJ

    更新日期:2018-03-30 00:00:00

  • Prognostic accuracy of WHO growth standards to predict mortality in a large-scale nutritional program in Niger.

    abstract:BACKGROUND:Important differences exist in the diagnosis of malnutrition when comparing the 2006 World Health Organization (WHO) Child Growth Standards and the 1977 National Center for Health Statistics (NCHS) reference. However, their relationship with mortality has not been studied. Here, we assessed the accuracy of t...

    journal_title:PLoS medicine

    pub_type: 杂志文章

    doi:10.1371/journal.pmed.1000039

    authors: Lapidus N,Luquero FJ,Gaboulaud V,Shepherd S,Grais RF

    更新日期:2009-03-03 00:00:00

  • Performance of the Access Bio/CareStart rapid diagnostic test for the detection of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis.

    abstract:BACKGROUND:To reduce the risk of drug-induced haemolysis, all patients should be tested for glucose-6-phosphate dehydrogenase (G6PD) deficiency (G6PDd) prior to prescribing primaquine (PQ)-based radical cure for the treatment of vivax malaria. This systematic review and individual patient meta-analysis assessed the uti...

    journal_title:PLoS medicine

    pub_type: 杂志文章,meta分析

    doi:10.1371/journal.pmed.1002992

    authors: Ley B,Winasti Satyagraha A,Rahmat H,von Fricken ME,Douglas NM,Pfeffer DA,Espino F,von Seidlein L,Henriques G,Oo NN,Menard D,Parikh S,Bancone G,Karahalios A,Price RN

    更新日期:2019-12-13 00:00:00

  • IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study.

    abstract:BACKGROUND:Pediatric acute lymphoblastic leukemia (ALL) is the most common childhood cancer and the leading cause of cancer-related mortality in children. T cell ALL (T-ALL) represents about 15% of pediatric ALL cases and is considered a high-risk disease. T-ALL is often associated with resistance to treatment, includi...

    journal_title:PLoS medicine

    pub_type: 杂志文章

    doi:10.1371/journal.pmed.1002200

    authors: Li Y,Buijs-Gladdines JG,Canté-Barrett K,Stubbs AP,Vroegindeweij EM,Smits WK,van Marion R,Dinjens WN,Horstmann M,Kuiper RP,Buijsman RC,Zaman GJ,van der Spek PJ,Pieters R,Meijerink JP

    更新日期:2016-12-20 00:00:00

  • Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study.

    abstract:BACKGROUND:A nonsputum blood test capable of predicting progression of healthy individuals to active tuberculosis (TB) before clinical symptoms manifest would allow targeted treatment to curb transmission. We aimed to develop a proteomic biomarker of risk of TB progression for ultimate translation into a point-of-care ...

    journal_title:PLoS medicine

    pub_type: 杂志文章

    doi:10.1371/journal.pmed.1002781

    authors: Penn-Nicholson A,Hraha T,Thompson EG,Sterling D,Mbandi SK,Wall KM,Fisher M,Suliman S,Shankar S,Hanekom WA,Janjic N,Hatherill M,Kaufmann SHE,Sutherland J,Walzl G,De Groote MA,Ochsner U,Zak DE,Scriba TJ,ACS and GC6–74

    更新日期:2019-04-16 00:00:00

  • A research agenda for malaria eradication: drugs.

    abstract::Antimalarial drugs will be essential tools at all stages of malaria elimination along the path towards eradication, including the early control or "attack" phase to drive down transmission and the later stages of maintaining interruption of transmission, preventing reintroduction of malaria, and eliminating the last r...

    journal_title:PLoS medicine

    pub_type: 杂志文章,评审

    doi:10.1371/journal.pmed.1000402

    authors: malERA Consultative Group on Drugs.

    更新日期:2011-01-25 00:00:00

  • Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis.

    abstract:BACKGROUND:Psychosis is a severe mental condition that is characterized by a loss of contact with reality and is typically associated with hallucinations and delusional beliefs. There are numerous psychiatric conditions that present with psychotic symptoms, most importantly schizophrenia, bipolar affective disorder, an...

    journal_title:PLoS medicine

    pub_type: 杂志文章

    doi:10.1371/journal.pmed.0030428

    authors: Huang JT,Leweke FM,Oxley D,Wang L,Harris N,Koethe D,Gerth CW,Nolden BM,Gross S,Schreiber D,Reed B,Bahn S

    更新日期:2006-11-01 00:00:00

  • Aberrant receptor-mediated endocytosis of Schistosoma mansoni glycoproteins on host lipoproteins.

    abstract:BACKGROUND:Bilharzia is one of the major parasitic infections affecting the public health and socioeconomic circumstances in (sub) tropical areas. Its causative agents are schistosomes. Since these worms remain in their host for decades, they have developed mechanisms to evade or resist the immune system. Like several ...

    journal_title:PLoS medicine

    pub_type: 杂志文章

    doi:10.1371/journal.pmed.0030253

    authors: Sprong H,Suchanek M,van Dijk SM,van Remoortere A,Klumperman J,Avram D,van der Linden J,Leusen JH,van Hellemond JJ,Thiele C

    更新日期:2006-08-01 00:00:00

  • Searching for Public Health Law's Sweet Spot: The Regulation of Sugar-Sweetened Beverages.

    abstract::David Studdert and colleagues explore how to balance public health, individual freedom, and good government when it comes to sugar-sweetened drinks. ...

    journal_title:PLoS medicine

    pub_type: 杂志文章

    doi:10.1371/journal.pmed.1001848

    authors: Studdert DM,Flanders J,Mello MM

    更新日期:2015-07-07 00:00:00

  • Effective coverage: a metric for monitoring Universal Health Coverage.

    abstract::A major challenge in monitoring universal health coverage (UHC) is identifying an indicator that can adequately capture the multiple components underlying the UHC initiative. Effective coverage, which unites individual and intervention characteristics into a single metric, offers a direct and flexible means to measure...

    journal_title:PLoS medicine

    pub_type: 杂志文章,评审

    doi:10.1371/journal.pmed.1001730

    authors: Ng M,Fullman N,Dieleman JL,Flaxman AD,Murray CJ,Lim SS

    更新日期:2014-09-22 00:00:00

  • Can animal models of disease reliably inform human studies?

    abstract::H. Bart van der Worp and colleagues discuss the controversies and possibilities of translating the results of animal experiments into human clinical trials. ...

    journal_title:PLoS medicine

    pub_type: 杂志文章

    doi:10.1371/journal.pmed.1000245

    authors: van der Worp HB,Howells DW,Sena ES,Porritt MJ,Rewell S,O'Collins V,Macleod MR

    更新日期:2010-03-30 00:00:00

  • Keeping it real: A journal editor in clinic.

    abstract::In this month's editorial, PLOS Medicine's Chief Editor Larry Peiperl discusses the relevance of patient care to a journal editor's work. ...

    journal_title:PLoS medicine

    pub_type: 社论

    doi:10.1371/journal.pmed.1002394

    authors: Peiperl L,PLOS Medicine Editors.

    更新日期:2017-09-26 00:00:00

  • The HIV Treatment Gap: Estimates of the Financial Resources Needed versus Available for Scale-Up of Antiretroviral Therapy in 97 Countries from 2015 to 2020.

    abstract:BACKGROUND:The World Health Organization (WHO) released revised guidelines in 2015 recommending that all people living with HIV, regardless of CD4 count, initiate antiretroviral therapy (ART) upon diagnosis. However, few studies have projected the global resources needed for rapid scale-up of ART. Under the Health Poli...

    journal_title:PLoS medicine

    pub_type: 杂志文章

    doi:10.1371/journal.pmed.1001907

    authors: Dutta A,Barker C,Kallarakal A

    更新日期:2015-11-24 00:00:00

  • Lymphocytic infiltration in stage II microsatellite stable colorectal tumors: A retrospective prognosis biomarker analysis.

    abstract:BACKGROUND:Identifying stage II patients with colorectal cancer (CRC) at higher risk of progression is a clinical priority in order to optimize the advantages of adjuvant chemotherapy while avoiding unnecessary toxicity. Recently, the intensity and the quality of the host immune response in the tumor microenvironment h...

    journal_title:PLoS medicine

    pub_type: 杂志文章

    doi:10.1371/journal.pmed.1003292

    authors: Sanz-Pamplona R,Melas M,Maoz A,Schmit SL,Rennert H,Lejbkowicz F,Greenson JK,Sanjuan X,Lopez-Zambrano M,Alonso MH,Qu C,McDonnell KJ,Idos GE,Vignali M,Emerson R,Fields P,Guinó E,Santos C,Salazar R,Robins HS,Rennert

    更新日期:2020-09-24 00:00:00

  • Anatomy of the epidemiological literature on the 2003 SARS outbreaks in Hong Kong and Toronto: a time-stratified review.

    abstract:BACKGROUND:Outbreaks of emerging infectious diseases, especially those of a global nature, require rapid epidemiological analysis and information dissemination. The final products of those activities usually comprise internal memoranda and briefs within public health authorities and original research published in peer-...

    journal_title:PLoS medicine

    pub_type: 杂志文章,评审

    doi:10.1371/journal.pmed.1000272

    authors: Xing W,Hejblum G,Leung GM,Valleron AJ

    更新日期:2010-05-04 00:00:00

  • Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in Uganda: a double-blind randomized non-inferiority trial.

    abstract:BACKGROUND:Postpartum hemorrhage (PPH) is a leading cause of maternal death in sub-Saharan Africa. Although the World Health Organization recommends use of oxytocin for prevention of PPH, misoprostol use is increasingly common owing to advantages in shelf life and potential for sublingual administration. There is a lac...

    journal_title:PLoS medicine

    pub_type: 杂志文章,随机对照试验

    doi:10.1371/journal.pmed.1001752

    authors: Atukunda EC,Siedner MJ,Obua C,Mugyenyi GR,Twagirumukiza M,Agaba AG

    更新日期:2014-11-04 00:00:00

  • New methodology for estimating the burden of infectious diseases in Europe.

    abstract::Mirjam Kretzschmar and colleagues describe the BCoDE project, which uses a pathogen-based incidence approach to better estimate the infectious disease burden in Europe. ...

    journal_title:PLoS medicine

    pub_type: 杂志文章

    doi:10.1371/journal.pmed.1001205

    authors: Kretzschmar M,Mangen MJ,Pinheiro P,Jahn B,Fèvre EM,Longhi S,Lai T,Havelaar AH,Stein C,Cassini A,Kramarz P,BCoDE consortium.

    更新日期:2012-01-01 00:00:00

  • Correction: Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study.

    abstract::[This corrects the article DOI: 10.1371/journal.pmed.1002781.]. ...

    journal_title:PLoS medicine

    pub_type: 已发布勘误

    doi:10.1371/journal.pmed.1002880

    authors: Penn-Nicholson A,Hraha T,Thompson EG,Sterling D,Mbandi SK,Wall KM,Fisher M,Suliman S,Shankar S,Hanekom WA,Janjic N,Hatherill M,Kaufmann SHE,Sutherland J,Walzl G,De Groote MA,Ochsner U,Zak DE,Scriba TJ,ACS and GC6–74

    更新日期:2019-07-18 00:00:00

  • Effect of tailoring anticoagulant treatment duration by applying a recurrence risk prediction model in patients with venous thromboembolism compared to usual care: A randomized controlled trial.

    abstract:BACKGROUND:Patients with unprovoked (i.e., without the presence of apparent transient risk factors such as recent surgery) venous thromboembolism (VTE) are at risk of recurrence if anticoagulants are stopped after 3-6 months, yet their risk remains heterogeneous. Thus, prolonging anticoagulant treatment should be consi...

    journal_title:PLoS medicine

    pub_type: 杂志文章,随机对照试验

    doi:10.1371/journal.pmed.1003142

    authors: Geersing GJ,Hendriksen JMT,Zuithoff NPA,Roes KC,Oudega R,Takada T,Schutgens REG,Moons KGM

    更新日期:2020-06-26 00:00:00

  • A collaborative epidemiological investigation into the criminal fake artesunate trade in South East Asia.

    abstract:BACKGROUND:Since 1998 the serious public health problem in South East Asia of counterfeit artesunate, containing no or subtherapeutic amounts of the active antimalarial ingredient, has led to deaths from untreated malaria, reduced confidence in this vital drug, large economic losses for the legitimate manufacturers, an...

    journal_title:PLoS medicine

    pub_type: 杂志文章

    doi:10.1371/journal.pmed.0050032

    authors: Newton PN,Fernández FM,Plançon A,Mildenhall DC,Green MD,Ziyong L,Christophel EM,Phanouvong S,Howells S,McIntosh E,Laurin P,Blum N,Hampton CY,Faure K,Nyadong L,Soong CW,Santoso B,Zhiguang W,Newton J,Palmer K

    更新日期:2008-02-01 00:00:00

  • Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgus macaques.

    abstract:BACKGROUND:Despite repeated outbreaks, in particular the devastating 2014-2016 epidemic, there is no effective treatment validated for patients with Ebola virus disease (EVD). Among the drug candidates is the broad-spectrum polymerase inhibitor favipiravir, which showed a good tolerance profile in patients with EVD (JI...

    journal_title:PLoS medicine

    pub_type: 杂志文章

    doi:10.1371/journal.pmed.1002535

    authors: Guedj J,Piorkowski G,Jacquot F,Madelain V,Nguyen THT,Rodallec A,Gunther S,Carbonnelle C,Mentré F,Raoul H,de Lamballerie X

    更新日期:2018-03-27 00:00:00

  • Reducing undiagnosed HIV infection among adolescents in sub-Saharan Africa: Provider-initiated and opt-out testing are not enough.

    abstract::Community efforts and peer support programs are needed in addition to provider-initiated and opt-out HIV testing in adolescents, Sheri Weiser and colleagues discuss. ...

    journal_title:PLoS medicine

    pub_type: 杂志文章

    doi:10.1371/journal.pmed.1002361

    authors: Lightfoot M,Dunbar M,Weiser SD

    更新日期:2017-07-25 00:00:00

  • Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial.

    abstract:BACKGROUND:TKM-130803, a small interfering RNA lipid nanoparticle product, has been developed for the treatment of Ebola virus disease (EVD), but its efficacy and safety in humans has not been evaluated. METHODS AND FINDINGS:In this single-arm phase 2 trial, adults with laboratory-confirmed EVD received 0.3 mg/kg of T...

    journal_title:PLoS medicine

    pub_type: 杂志文章

    doi:10.1371/journal.pmed.1001997

    authors: Dunning J,Sahr F,Rojek A,Gannon F,Carson G,Idriss B,Massaquoi T,Gandi R,Joseph S,Osman HK,Brooks TJ,Simpson AJ,Goodfellow I,Thorne L,Arias A,Merson L,Castle L,Howell-Jones R,Pardinaz-Solis R,Hope-Gill B,Ferri M,

    更新日期:2016-04-19 00:00:00

  • Comparison of aggregate and individual participant data approaches to meta-analysis of randomised trials: An observational study.

    abstract:BACKGROUND:It remains unclear when standard systematic reviews and meta-analyses that rely on published aggregate data (AD) can provide robust clinical conclusions. We aimed to compare the results from a large cohort of systematic reviews and meta-analyses based on individual participant data (IPD) with meta-analyses o...

    journal_title:PLoS medicine

    pub_type: 杂志文章

    doi:10.1371/journal.pmed.1003019

    authors: Tierney JF,Fisher DJ,Burdett S,Stewart LA,Parmar MKB

    更新日期:2020-01-31 00:00:00

  • Correction: association between cutaneous nevi and breast cancer in the nurses' health study: a prospective cohort study.

    abstract::[This corrects the article DOI: 10.1371/journal.pmed.1001659.]. ...

    journal_title:PLoS medicine

    pub_type: 已发布勘误

    doi:10.1371/journal.pmed.1001797

    authors: PLOS Medicine Staff.

    更新日期:2015-03-03 00:00:00

  • The effect of alpha+-thalassaemia on the incidence of malaria and other diseases in children living on the coast of Kenya.

    abstract:BACKGROUND:The alpha-thalassaemias are the commonest genetic disorders of humans. It is generally believed that this high frequency reflects selection through a survival advantage against death from malaria; nevertheless, the epidemiological description of the relationships between alpha-thalassaemia, malaria, and othe...

    journal_title:PLoS medicine

    pub_type: 杂志文章

    doi:10.1371/journal.pmed.0030158

    authors: Wambua S,Mwangi TW,Kortok M,Uyoga SM,Macharia AW,Mwacharo JK,Weatherall DJ,Snow RW,Marsh K,Williams TN

    更新日期:2006-05-01 00:00:00

  • Estimated health benefits, costs, and cost-effectiveness of eliminating industrial trans-fatty acids in Australia: A modelling study.

    abstract:BACKGROUND:trans-fatty acids (TFAs) are a well-known risk factor of ischemic heart disease (IHD). In Australia, the highest TFA intake is concentrated to the most socioeconomically disadvantaged groups. Elimination of industrial TFA (iTFA) from the Australian food supply could result in reduced IHD mortality and morbid...

    journal_title:PLoS medicine

    pub_type: 杂志文章

    doi:10.1371/journal.pmed.1003407

    authors: Marklund M,Zheng M,Veerman JL,Wu JHY

    更新日期:2020-11-02 00:00:00

  • Evidence of a causal relationship between body mass index and psoriasis: A mendelian randomization study.

    abstract:BACKGROUND:Psoriasis is a common inflammatory skin disease that has been reported to be associated with obesity. We aimed to investigate a possible causal relationship between body mass index (BMI) and psoriasis. METHODS AND FINDINGS:Following a review of published epidemiological evidence of the association between o...

    journal_title:PLoS medicine

    pub_type: 杂志文章,meta分析

    doi:10.1371/journal.pmed.1002739

    authors: Budu-Aggrey A,Brumpton B,Tyrrell J,Watkins S,Modalsli EH,Celis-Morales C,Ferguson LD,Vie GÅ,Palmer T,Fritsche LG,Løset M,Nielsen JB,Zhou W,Tsoi LC,Wood AR,Jones SE,Beaumont R,Saunes M,Romundstad PR,Siebert S,McInn

    更新日期:2019-01-31 00:00:00

  • Global mortality estimates for the 2009 Influenza Pandemic from the GLaMOR project: a modeling study.

    abstract:BACKGROUND:Assessing the mortality impact of the 2009 influenza A H1N1 virus (H1N1pdm09) is essential for optimizing public health responses to future pandemics. The World Health Organization reported 18,631 laboratory-confirmed pandemic deaths, but the total pandemic mortality burden was substantially higher. We estim...

    journal_title:PLoS medicine

    pub_type: 杂志文章

    doi:10.1371/journal.pmed.1001558

    authors: Simonsen L,Spreeuwenberg P,Lustig R,Taylor RJ,Fleming DM,Kroneman M,Van Kerkhove MD,Mounts AW,Paget WJ,GLaMOR Collaborating Teams.

    更新日期:2013-11-01 00:00:00